- Home
- AUTL vs MIY Comparison
AUTL vs MIY Comparison
Compare AUTL & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.59
Company Overview
Basic Information| Metric | AUTL | MIY |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.2M | 354.5M |
| IPO Year | 2025 | 1994 |
Fundamental Metrics
Financial Performance| Metric | AUTL | MIY |
|---|---|---|
| Price | $1.59 | $11.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 65.7K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $80.32 | N/A |
| Revenue Next Year | $53.96 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.15 | $10.57 |
| 52 Week High | $2.70 | $12.90 |
Technical Indicators
Market Signals| Indicator | AUTL | MIY |
|---|---|---|
| Relative Strength Index (RSI) | 59.85 | 44.28 |
| Support Level | $1.22 | $11.23 |
| Resistance Level | $1.69 | $11.89 |
| Average True Range (ATR) | 0.08 | 0.31 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 74.03 | 46.96 |
Price Performance
Historical Comparison AUTL
MIY
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.